AR028028A1 - Preparacion liquida estabilizada - Google Patents

Preparacion liquida estabilizada

Info

Publication number
AR028028A1
AR028028A1 ARP010101885A ARP010101885A AR028028A1 AR 028028 A1 AR028028 A1 AR 028028A1 AR P010101885 A ARP010101885 A AR P010101885A AR P010101885 A ARP010101885 A AR P010101885A AR 028028 A1 AR028028 A1 AR 028028A1
Authority
AR
Argentina
Prior art keywords
liquid preparation
stabilized liquid
stabilized
preparation
liquid
Prior art date
Application number
ARP010101885A
Other languages
English (en)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of AR028028A1 publication Critical patent/AR028028A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP010101885A 2000-04-24 2001-04-24 Preparacion liquida estabilizada AR028028A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000127622 2000-04-24
JP2000149812 2000-05-17

Publications (1)

Publication Number Publication Date
AR028028A1 true AR028028A1 (es) 2003-04-23

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101885A AR028028A1 (es) 2000-04-24 2001-04-24 Preparacion liquida estabilizada

Country Status (20)

Country Link
US (1) US7304075B2 (es)
EP (1) EP1277471B1 (es)
JP (1) JP5027975B2 (es)
KR (1) KR100858228B1 (es)
CN (1) CN1326524C (es)
AR (1) AR028028A1 (es)
AT (1) ATE396729T1 (es)
AU (1) AU2001248833A1 (es)
BR (1) BR0110290A (es)
CA (1) CA2406849C (es)
DE (1) DE60134221D1 (es)
DK (1) DK1277471T3 (es)
ES (1) ES2305065T3 (es)
HK (1) HK1050326A1 (es)
MX (1) MXPA02010497A (es)
NO (1) NO323810B1 (es)
PT (1) PT1277471E (es)
RU (1) RU2295342C2 (es)
TW (1) TWI280131B (es)
WO (1) WO2001080858A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1525884B1 (en) 2002-07-31 2011-10-12 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
US20100249413A1 (en) 2006-08-25 2010-09-30 Makoto Murai Stabilized pharmaceutical composition
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
CN110917130A (zh) * 2012-06-27 2020-03-27 武田药品工业株式会社 用盐稳定的胺和有机酸的液体制剂
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274989A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Manufacturing beta-lactam combination products
ES2800603T3 (es) 2013-09-09 2021-01-04 Merck Sharp & Dohme Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека
EP0470252A4 (en) 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug

Also Published As

Publication number Publication date
US20030139436A1 (en) 2003-07-24
MXPA02010497A (es) 2003-05-14
KR20020089523A (ko) 2002-11-29
NO20025081L (no) 2002-12-23
DK1277471T3 (da) 2008-08-11
JP5027975B2 (ja) 2012-09-19
HK1050326A1 (en) 2003-06-20
EP1277471A4 (en) 2006-04-12
WO2001080858A1 (fr) 2001-11-01
CN1326524C (zh) 2007-07-18
ATE396729T1 (de) 2008-06-15
AU2001248833A1 (en) 2001-11-07
CA2406849C (en) 2007-10-23
ES2305065T3 (es) 2008-11-01
RU2295342C2 (ru) 2007-03-20
CA2406849A1 (en) 2002-10-21
DE60134221D1 (de) 2008-07-10
RU2002128631A (ru) 2004-03-27
EP1277471B1 (en) 2008-05-28
CN1438888A (zh) 2003-08-27
BR0110290A (pt) 2003-02-18
KR100858228B1 (ko) 2008-09-12
TWI280131B (en) 2007-05-01
NO323810B1 (no) 2007-07-09
EP1277471A1 (en) 2003-01-22
PT1277471E (pt) 2008-08-26
NO20025081D0 (no) 2002-10-22
US7304075B2 (en) 2007-12-04

Similar Documents

Publication Publication Date Title
DE60109466D1 (de) Flüssigkristallmischung
DE60129488D1 (de) Anzeigegerät
DE60140125D1 (de) Ertragenem inhalt
ATE349896T1 (de) Flüssige brotverbesserungsmittel
NO20003968D0 (no) Farmasøytiske preparater
DE50106762D1 (de) Ionische Flüssigkeiten
AR028461A1 (es) Composicion detergente liquida
DK1278416T3 (da) Flydende præparater
NO20023367L (no) Glyburide-preparat
AR028028A1 (es) Preparacion liquida estabilizada
FR2810866B1 (fr) Presentoir
DE60042344D1 (de) Bordeigenes anzeigesystem
IS6698A (is) Háhreinsaðar símvastatínblöndur
DK1331972T3 (da) Farmaceutiske præparater
DE50100116D1 (de) Vertikalmischer
DE10196460T1 (de) Selbstzerstör-Spritze
PT1287095E (pt) Mistura de gasolina-oxigenato
DE50109358D1 (de) Flüssigkristall-Anzeige
DK1390133T3 (da) Drikkevaremixer
DE50105745D1 (de) Anzeigeeinrichtung
FI20001407A0 (fi) Nestepakkaus
DK200000333U3 (da) Diabetespræparat
UA4157S (uk) Дизелевіз рудниковий
FI20001804A0 (fi) Nesteen annostelu
FI990200A0 (fi) Nesteseostin

Legal Events

Date Code Title Description
FB Suspension of granting procedure